Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.rec.2017.06.015 | DOI Listing |
JACC Cardiovasc Interv
January 2025
Department of Cardiology, St. Johannes Hospital, Dortmund, Germany.
Background: Mid-term comparative data for the self-expanding ACURATE neo2 transcatheter heart valve and the balloon-expandable SAPIEN 3 Ultra are lacking.
Objectives: The aim of this study was to compare 1-year outcomes after transcatheter aortic valve replacement of these 2 valves.
Methods: A total of 2,106 patients from 3 centers (neo2, n = 1,166; Ultra, n = 940) undergoing transfemoral transcatheter aortic valve replacement were analyzed retrospectively.
Circ Cardiovasc Interv
November 2024
Department of Cardiology (G.J.C., D.E., C.S., C.J.C., J.M.M.), University of Washington School of Medicine, Seattle.
Background: Mitral annular calcification with valve dysfunction remains a challenging syndrome. Operative risk is high, and available transcatheter therapies are limited.
Methods: This study describes our initial experience with a novel procedure to address large mitral annuli when no surgical or trial-based transcatheter mitral valve replacement device is available.
Tex Heart Inst J
November 2024
Division of Interventional Cardiology, La Paz University Hospital, Madrid, Spain.
Transcatheter heart valve embolization is a serious and rare complication of transcatheter aortic valve replacement. Having a strategy for promptly managing transcatheter heart valve embolization is crucial to avoid emergency conversion from transcatheter aortic valve replacement to open-heart surgery. Many cases of transcatheter heart valve embolization occurring with balloon-expandable prostheses such as the SAPIEN 3 (Edwards LifeSciences Corporation) valve and self-expandable prostheses such as the ACURATE neo (Boston Scientific Corporation) valve have been reported in the literature.
View Article and Find Full Text PDFCardiovasc Interv Ther
January 2025
Division of Cardiology, Department of Internal Medicine, Kindai University Faculty of Medicine, OSAKA, Japan.
The hemodynamic impact of the implantation depth for balloon-expandable valves is under-investigated, especially with higher implantation techniques. We assessed the hemodynamic performance of supra-annular SAPIEN 3 valve implantation. This retrospective study involved consecutive patients who underwent transcatheter aortic valve replacement (TAVR) using the SAPIEN 3.
View Article and Find Full Text PDFCardiovasc Revasc Med
August 2024
Clinical and Interventional Cardiology Department, I.R.C.C.S. Policlinico San Donato, San Donato Milanese, Milan, Italy. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!